CYTIVA

Rockwell Automation and Cytiva Launch Platform to Accelerate Digital Transformation for Biopharma Companies

Automation.com · 5 days ago

Rockwell Automation and Cytiva join hands to accelerate digital transformation for biopharma companies

BioSpectrum Asia · 10 days ago

Yoshindo Builds In-House Biosimilars Capacity With Cytiva Support

Citeline News & Insights · about 2 months ago

Yoshindo And Cytiva Strengthen Japan’s Biologics Sovereignty Through Scalable Modular Manufacturing

BioPharma APAC · about 2 months ago

Cytiva and Yoshindo advance domestic biosimilar manufacturing in Japan

BioSpectrum Asia · about 2 months ago

Cytiva enters research partnership with SRTIGET for next-gen genomic medicine

Manufacturing Chemist · about 2 months ago

Cytiva-SR-TIGET Joint Venture Addresses Gene Therapy Bottlenecks

Inside Precision Medicine · about 2 months ago

How Cytiva Unified MedTech and BioTech Regulatory Divisions with Veeva RIM

Veeva · 3 months ago

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More

Yahoo Finance · 3 months ago

Cytiva and Fida Biosystems collaborate to improve molecular insight for faster drug discovery

BioSpectrum Asia · 5 months ago

Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein Research

Contract Pharma · 5 months ago

Cytiva’s strategic expansion in Western Switzerland’s Health Valley

S-GE · 6 months ago

Korea rises to 3rd on Cytiva’s global biopharma index in R&D, talent strength

koreabiomed.com · 7 months ago

Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown

BioPharma APAC · 7 months ago

Cytiva Expands Collaboration with Culture Biosciences

Genetic Engineering and Biotechnology News · 9 months ago

"In-Region, For Region": Cytiva Builds Out $1.6B in Global Expansion Projects

Genetic Engineering and Biotechnology News · 10 months ago

Cytiva outlines $1.6bn facility investment plans through 2028

BioProcess International · 11 months ago